carvacrol has been researched along with Leiomyosarcoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daskalou, T; Evangelou, AM; Karamouzis, M; Karkabounas, S; Kostoula, OK; Kotsis, N; Lekkas, P; Metsios, A; Skoufos, I; Veltsistas, P; Zelovitis, I | 1 |
1 other study(ies) available for carvacrol and Leiomyosarcoma
| Article | Year |
|---|---|
Anticarcinogenic and antiplatelet effects of carvacrol.
Topics: Animals; Anticarcinogenic Agents; Benzo(a)pyrene; Blood Platelets; Cell Proliferation; Cymenes; Leiomyosarcoma; Male; Monoterpenes; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Thromboxane B2 | 2006 |